Displaying 1 - 50 of 71 results
Released Company Title Industry Topic
08 Sep 2021
15:48 CEST
GENTIAN DIAGNOSTICS ASA Norron Sicav Flagging i Gentian Diagnostics ASA 20103010 Biotechnology Flagging
26 Aug 2021
08:16 CEST
GENTIAN DIAGNOSTICS ASA Flaggemelding, Salix AS - Gentian Diagnostics ASA 20103010 Biotechnology Flagging
25 Aug 2021
18:38 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade and disclosure of large shareholding 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Aug 2021
08:00 CEST
GENTIAN DIAGNOSTICS ASA Second quarter 2021 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
19 Aug 2021
13:00 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of second quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 Jun 2021
11:48 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics ASA – Approval and publication of prospectus, and transfer of listing from Euronext Growth (Oslo) to Oslo Børs 20103010 Biotechnology Prospectus / admission document
23 Jun 2021
11:48 CEST
GENTIAN DIAGNOSTICS ASA Transfer of shares to Oslo Børs approved, prepared for accelerated growth 20103010 Biotechnology Non-regulatory press releases
23 Jun 2021
10:53 CEST
GENTIAN DIAGNOSTICS ASA Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
23 Jun 2021
10:53 CEST
GENTIAN DIAGNOSTICS ASA Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs – Gentian Diagnostics ASA 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
18 Jun 2021
07:30 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: Invitation to virtual presentation at 24 June 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
18 Jun 2021
07:15 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
14:22 CEST
GENTIAN DIAGNOSTICS Application for transfer of shares admitted to trading on Euronext Growth to to Oslo Børs 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
14:22 CEST
GENTIAN DIAGNOSTICS Søknad om overføring av aksjer tatt opp til handel fra Euronext Growth til Oslo Børs 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
07 May 2021
13:57 CEST
GENTIAN DIAGNOSTICS Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 May 2021
10:28 CEST
GENTIAN DIAGNOSTICS Gentian Diagnostics ASA – conversion to public limited liability company registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 May 2021
20:18 CEST
GENTIAN DIAGNOSTICS Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Apr 2021
22:14 CEST
GENTIAN DIAGNOSTICS 2021 Annual general meeting - proposal from the nomination committee 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Apr 2021
08:33 CEST
GENTIAN DIAGNOSTICS Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Apr 2021
12:37 CEST
GENTIAN DIAGNOSTICS Annual report 2020 20103010 Biotechnology Annual financial and audit Reports
16 Apr 2021
08:15 CEST
GENTIAN DIAGNOSTICS First quarter 2021 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
12 Apr 2021
13:55 CEST
GENTIAN DIAGNOSTICS Presentation of 2021 first quarter results for Gentian Diagnostics AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
18 Feb 2021
12:02 CET
GENTIAN DIAGNOSTICS Publication of NT-proBNP patent application 20103010 Biotechnology Non-regulatory press releases
11 Feb 2021
08:00 CET
GENTIAN DIAGNOSTICS 4Q 2020 Results and preliminary annual report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
05 Feb 2021
08:39 CET
GENTIAN DIAGNOSTICS Presentation of 2020 fourth quarter results for Gentian Diagnostics AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Jan 2021
08:15 CET
Gentian Diagnostics SARS-CoV-2 antibody test moving to the next development phase 20103010 Biotechnology Non-regulatory press releases
17 Dec 2020
08:47 CET
Gentian Diagnostics Share capital increase registered 20103010 Biotechnology Total number of voting rights and capital
15 Dec 2020
09:17 CET
Gentian Diagnostics Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
14 Dec 2020
08:20 CET
Gentian Diagnostics Gentian and research partners with two posters related to the value of calprotectin in management of COVID-19 patients at the AACC 20103010 Biotechnology Non-regulatory press releases
09 Dec 2020
10:51 CET
Gentian Diagnostics Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
09 Dec 2020
10:51 CET
Gentian Diagnostics Finansiell kalender 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
04 Dec 2020
09:32 CET
Gentian Diagnostics Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
04 Dec 2020
09:28 CET
Gentian Diagnostics Share issue in connection with employee share purchase program 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
20 Nov 2020
09:54 CET
Gentian Diagnostics New study results confirm the value of calprotectin in management of COVID-19 patients 20103010 Biotechnology Non-regulatory press releases
12 Nov 2020
18:49 CET
Gentian Diagnostics Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
05 Nov 2020
12:21 CET
Gentian Diagnostics Gentian Diagnostics divests its subsidiary PreTect AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Oct 2020
07:45 CET
Gentian Diagnostics Thrid quarter 2020 financial repor 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Oct 2020
14:41 CEST
Gentian Diagnostics Presentation of 2020 third quarter results for Gentian Diagnostics AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
02 Sep 2020
09:47 CEST
Gentian Diagnostics Gentian Diagnostics presents at the Pareto Healtcare conference 20103010 Biotechnology Non-regulatory press releases
27 Aug 2020
14:58 CEST
Gentian Diagnostics STUDY CONFIRMS SIGNIFICANTLY ELEVATED LEVELS OF CALPROTECTIN IN PATIENTS WITH SEVERE COVID-19 20103010 Biotechnology Non-regulatory press releases
27 Aug 2020
11:53 CEST
Gentian Diagnostics Primary insider notification - Korr 20103010 Biotechnology Mandatory notification of trade primary insiders
27 Aug 2020
11:10 CEST
Gentian Diagnostics Primary insider notification 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Aug 2020
08:00 CEST
Gentian Diagnostics 2nd quarter and first half 2020 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
14 Aug 2020
09:49 CEST
Gentian Diagnostics Presentation of second quarter and first half results for 2020 for Gentian Diagnostics AS 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
03 Jul 2020
08:23 CEST
Gentian Diagnostics Gentian awarded up to NOK 8.0 million funding to develop a novel high-throughput COVID-19 antibody test 20103010 Biotechnology Inside information
16 Jun 2020
14:39 CEST
Gentian Diagnostics Release of BÜHLMANN fPELA® turbo 20103010 Biotechnology Non-regulatory press releases
14 May 2020
12:37 CEST
Gentian Diagnostics Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Apr 2020
12:46 CEST
Gentian Diagnostics Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 Apr 2020
09:31 CEST
Gentian Diagnostics 2019 Annual Report 20103010 Biotechnology Annual financial and audit Reports
24 Apr 2020
09:11 CEST
Gentian Diagnostics Flaggemelding Gentian Diagnostics AS 20103010 Biotechnology Flagging
24 Apr 2020
08:57 CEST
Gentian Diagnostics Melding vedrørende handel 20103010 Biotechnology Flagging